Redmile Group’s Merck MRK Stock Holding History

Redmile Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-296,060	Closed	-$14.1M	–	62
2013 Q4	$14.1M	Hold	296,060	–	–	1.74%	27
2013 Q3	$13.4M	Buy	296,060 +34,060	+13%	+$1.56M	2.03%	22
2013 Q2	$11.6M	Buy	+262,000	New	+$11.7M	2.05%	20

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Redmile Group's MRK Position: Q3 2020 in Review

Redmile Group sold out of Merck (MRK) in Q3 2020, closing a stake of 549,466 shares — an estimated $40.5M sold.

Redmile Group first reported a position in MRK in Q3 2013 and held it in 4 quarters. The position peaked at $60.7M in Q1 2020. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

Redmile Group reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
Redmile Group sold 549,466 Merck shares in Q3 2020, an estimated $40.5M.
Redmile Group first reported a position in Merck in Q3 2013 and held it in 4 quarters.
Redmile Group's Merck position peaked at $60.7M in Q1 2020.
2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Redmile Group's 13F filing for Q3 2020, filed 16 Nov 2020.